In bleomycin-induced lung fibrosis, genetic ablation of BAFF or BAFF neutralization by a soluble receptor significantly attenuates pulmonary fibrosis and IL-1β levels (30). This evidence concerns the gene IL1B and pulmonary fibrosis.